11 April 2014
Monica Healthcare secures N'Tech grant
A University of Nottingham spin-out has been awarded a grant of more than £250,000 to support a further £1m investment into the business. Monica Healthcare, based at BioCity, is led by Dr Carl Barratt. The company has developed a foetal and maternal monitor, which is...
8 April 2014
Oxford Cryosystems helps push the boundaries of the known universe
Senior management from Oxfordshire-based business Oxford Cryosystems are celebrating their involvement in a global project to create what will eventually become the largest and most sensitive radio telescope on earth. Directors Richard Glazer and Alex Renshaw joined a delegation...
1 April 2014
Onwards and upwards for BWB Birmingham
2013/14 has been a truly remarkable year for BWB’s Birmingham office. Fuelled by successful appointments on a spate of regionally significant projects such as Severn Trent Water’s HQ in Coventry and Resorts World at the NEC, staff numbers in the office is expected to...
27 March 2014
Sprue Aegis plc (“Sprue”) and Intamac to launch connected safety solution
Intamac Systems Limited announces a new 3 year partnership agreement with Sprue, one of Europe’s leading suppliers of home safety products including smoke and carbon monoxide alarms sold under the FireAngel brand. Under the partnership, Sprue will launch an internet...
19 March 2014
Biofortuna receives FDA clearance of its SSPGo™ line of HLA molecular diagnostic freeze-dried kits
Biofortuna, a UK based molecular diagnostics company with proprietary freeze drying (lyophilizing) technology, has received FDA 510K clearance for its line of SSPGo™ HLA PCR kits. The SSPGo HLA Typing Kits are qualitative DNA-based kits for determining HLA alleles in low...
7 March 2014
New England Biolabs® announces supply agreement with Lumora
5th March, 2014 (Ipswich, MA, USA) New England Biolabs, Inc. (NEB®), a world leader in the production and supply of recombinant enzymes and related reagents for the life science industry, has strengthened its position as a key supplier to the fast-growing molecular...
26 February 2014
Prime Minister David Cameron visits portfolio company Oxford Cryosystems
The Prime Minister, David Cameron, recently visited Oxford Cryosystems in Long Hanborough to meet executives and staff from the market-leading manufacturer of specialist scientific instrumentation and software. During his visit, Mr Cameron toured the production site with...
29 January 2014
Michelson Diagnostics targets malignant melanoma using OCT imaging with €2.3M EU funding
Portfolio company Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, announces that the European Union has awarded a €2.26 million Framework 7 grant to a consortium of seven partners...
13 January 2014
Michelson Diagnostics announces £1.98 million financing
Portfolio company Michelson Diagnostics, the UK based medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, is delighted to announce the first closing of its Series A2 Financing. The round, which was oversubscribed, raised...
11 December 2013
Oxford BioTherapeutics and Menarini Progress Enhanced Antibody for Acute Myeloid Leukemia in $1 Billion Oncology Investment Alliance
OXFORD, UK and BERLIN CHEMIE/MENARINI, GERMANY – 9th December 2013 – Oxford BioTherapeutics (OBT) and Berlin-Chemie (Menarini Group) announce today that they have designated a novel enhanced antibody targeting acute myeloid leukemia (AML) as the first clinical...